Discover more insights into Immunotherapy Trials

Keywords frequently search together with Immunotherapy Trials

Narrow sentence examples with built-in keyword filters

Immunotherapy Trials sentence examples within Cancer Immunotherapy Trials



STING suppresses cancer pain via immune and neuronal modulation



In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome


Immunotherapy Trials sentence examples within Future Immunotherapy Trials



LAG-3 expression in the inflammatory microenvironment of glioma



Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: a role of CD163+ M2 macrophages, B cells and PD-L1 immune checkpoint


Immunotherapy Trials sentence examples within Combination Immunotherapy Trials



Clinical Trials in Metastatic Uveal Melanoma: Immunotherapy



Abstract 4043: Application of high complexity flow cytometry for Monitoring activated T-cells, T and B regulatory subsets in combination immunotherapy trials, melanoma case study



Learn more from Immunotherapy Trials


Immunotherapy Trials sentence examples within immunotherapy trials network



Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma



Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.



Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma



Clinical Trials in Metastatic Uveal Melanoma: Immunotherapy



Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors



Paving the Way for Immunotherapy in Pediatric Acute Myeloid Leukemia: Current Knowledge and the Way Forward


More Immunotherapy Trials sentence examples
10.1186/s13046-021-02078-3

Cyclin G2 reverses immunosuppressive tumor microenvironment and potentiates PD-1 blockade in glioma


More Immunotherapy Trials sentence examples
10.1080/13543784.2021.1974838

Atezolizumab: an investigational agent for the treatment of biliary tract cancer.


More Immunotherapy Trials sentence examples
10.1007/s11060-021-03721-x

LAG-3 expression in the inflammatory microenvironment of glioma



Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: a role of CD163+ M2 macrophages, B cells and PD-L1 immune checkpoint



Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus


More Immunotherapy Trials sentence examples
10.1200/JCO.2021.39.15_SUPPL.9565

Multicentre retrospective assessment of toxicity and response to immunotherapy in elderly patients with metastatic melanoma.



Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials



STING suppresses cancer pain via immune and neuronal modulation


More Immunotherapy Trials sentence examples
10.1038/s41575-021-00461-1

T cells in NASH and liver cancer: pathology and immunotherapy


More Immunotherapy Trials sentence examples
10.1200/JCO.2021.39.15_SUPPL.12104

CD4+ T-cell count eligibility by HIV status among participants receiving immunotherapy for cancer diagnoses.



Neuroendocrine Carcinomas of the Digestive Tract: What Is New?


More Immunotherapy Trials sentence examples
10.1007/s12254-021-00751-z

ASCO 2021–Gastroesophageal tumor highlights



Engineered Multifunctional Nano- and Biological Materials for Cancer Immunotherapy.


More Immunotherapy Trials sentence examples
10.1101/2021.09.09.21263319

In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome


More Immunotherapy Trials sentence examples
10.1016/j.vaccine.2021.08.026

A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment.


More Immunotherapy Trials sentence examples
10.1016/j.ijrobp.2021.07.1303

Role of Thoracic Radiotherapy in Extensive Stage Small Cell Lung Cancer (ES-SCLC) in the Immunotherapy Era: A National Hospital-Based Registry Analysis.



Use of immunotherapy with programmed cell death 1 vs programmed cell death ligand 1 in renal cell carcinoma: Lessons from CheckMate 9ER and IMmotion 151



A universal CAR-NK cell approach for HIV eradication



Adjuvant Systemic Therapy for High-risk Muscle-invasive Bladder Cancer After Radical Cystectomy: Current Options and Future Opportunities.


More Immunotherapy Trials sentence examples
10.1007/s00401-021-02318-y

Tau immunotherapy is associated with glial responses in FTLD-tau



Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis


More Immunotherapy Trials sentence examples
10.1080/13543784.2021.1916467

The challenges of combinatory immunotherapy for biliary tract cancer


More Immunotherapy Trials sentence examples
10.1016/j.jtocrr.2021.100149

Current Landscape of Immunotherapy Trials Involving the Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Axis in Intrathoracic Tumors



What does it mean to be food allergic?


More Immunotherapy Trials sentence examples
10.1093/braincomms/fcab030

Thyroid antibodies: the end of an era?



Cost-Effectiveness of Low-dose Antithymocyte Globulin versus Other Immunotherapies for Treatment of New-Onset Type 1 Diabetes.



Successful Use of Immunotherapy in a Patient with Metastatic Squamous Cell Lung Cancer and Underlying Autoimmune Disease



Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma



Cytokine storm induced by a PD1 inhibitor in a renal transplant patient



Nation-Wide Trends in Incidence-Based Mortality of Patients with Ocular Melanoma in USA: 2000 to 2018



Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer



Immunotherapy



A weighted log-rank test and associated effect estimator for cancer trials with delayed treatment effect.


More Immunotherapy Trials sentence examples
10.1200/JCO.2021.39.15_SUPPL.9584

Increased risk of immune-related hepatitis among adolescent and young adults (AYAs) with melanoma during immunotherapy with checkpoint inhibitors (ICIs).


More Immunotherapy Trials sentence examples
10.1038/s41391-021-00340-5

How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer


More Immunotherapy Trials sentence examples
10.1136/bmjno-2021-anzan.7

007 Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies



Single dose of atezolizumab plus chemotherapy in active psoriasis with advanced non-small cell lung cancer.


More Immunotherapy Trials sentence examples
10.1186/s13024-021-00453-4

Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy


More Immunotherapy Trials sentence examples
10.1016/j.euros.2021.05.002

Sexual Dimorphism in Outcomes of Non–muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune Checkpoint


More Immunotherapy Trials sentence examples
10.1136/medethics-2021-107800

Commentary to ‘Novel drug candidates targeting Alzheimer’s disease: ethical challenges with identifying the relevant patient population’


More Immunotherapy Trials sentence examples
10.1080/2162402X.2021.1974233

Tumor hypoxia: an important regulator of tumor progression or a potential modulator of tumor immunogenicity?



Single Cell T Cell Receptor Repertoire Profiling for Dogs


More Immunotherapy Trials sentence examples
10.1016/j.critrevonc.2021.103460

Dynamics of eligibility criteria for central nervous system metastases in non-small cell lung cancer randomized clinical trials over time: A systematic review.



Considerations for treatment duration in responders to immune checkpoint inhibitors



How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?


More Immunotherapy Trials sentence examples
10.1016/j.currproblcancer.2021.100777

Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.



Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer



RNA-Seq Analysis Reveals CCR5 as a Key Target for CRISPR Gene Editing to Regulate In Vivo NK Cell Trafficking



Oral tolerance and the materno-fetal relationship.



The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy



Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability



Failure After Failure. What Next in AD Drug Development?



Progression‐free survival and one‐year milestone survival as surrogates for overall survival in previously treated advanced non‐small cell lung cancer



Differential expression of immunoregulatory molecules and highly-associated cancer genes may provide novel insights into strategic trial design for therapeutics



Is Earlier Better? Immunotherapy for Resectable Lung Cancer


More Immunotherapy Trials sentence examples
10.1038/s41467-019-12361-9

Metabolomic adaptations and correlates of survival to immune checkpoint blockade


More Immunotherapy Trials sentence examples
10.1634/theoncologist.2019-0473

Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study.


More Immunotherapy Trials sentence examples
10.1080/10543406.2019.1633654

Rapid enrollment design for finding the optimal dose in immunotherapy trials with ordered groups


More Immunotherapy Trials sentence examples
10.1158/1538-7445.AM2019-4467

Abstract 4467: Survival of patients with microsatellite instable (MSI) metastatic colorectal cancer (mCRC) upon systemic non-immunotherapy



Immunotherapy of hepatocellular carcinoma: strategies for combinatorial intervention


More Immunotherapy Trials sentence examples
10.1158/1538-7445.SABCS18-4043

Abstract 4043: Application of high complexity flow cytometry for Monitoring activated T-cells, T and B regulatory subsets in combination immunotherapy trials, melanoma case study


More Immunotherapy Trials sentence examples
10.1158/1541-7786.MCR-19-0449

Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian Cancer


More Immunotherapy Trials sentence examples
10.1136/esmoopen-2018-000477

Early use of steroids affects immune cells and impairs immunotherapy efficacy



Retrospective analysis of immunotherapy prognostic scores in advanced NSCLC at Nottingham University Hospitals (UK)


More Immunotherapy Trials sentence examples
10.1080/10543406.2019.1643360

Guest editors’ note on special issue on real-world experience and randomized clinical trials


More Immunotherapy Trials sentence examples
10.1016/j.jaci.2018.12.495

Doses of Specific Allergens in Early Peanut Intervention Products Associated with Prevention of Peanut Allergy: 492



Cancer immunotherapy trial design with cure rate and delayed treatment effect.


More Immunotherapy Trials sentence examples
10.1007/978-1-4939-9597-4_25

Immunoproteomic Biomarkers: From Publication to Personalized Medicine.


More Immunotherapy Trials sentence examples
10.1016/j.jaad.2019.07.005

Immune checkpoint inhibitor therapy in solid organ transplant recipients: A patient-centered systematic review.



Gustave Roussy Immune Score Is a Prognostic Factor for Chemotherapy-Naive Pulmonary Adenocarcinoma With Wild-Type Epidermal Growth Factor Receptor


More Immunotherapy Trials sentence examples
10.1158/2326-6074.CRICIMTEATIAACR18-A114

Abstract A114: Omental fat in ovarian cancer induces metabolic and immune alterations



Immunotherapy and the A2A Adenosine Receptor: A Confounding Brew



Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.


Learn more from Immunotherapy Trials


Immunotherapy Trials
Encyclopedia